SwePub
Sök i LIBRIS databas

  Extended search

WFRF:(Cockcroft K)
 

Search: WFRF:(Cockcroft K) > (2015-2019) > Lung Function Abnor...

Lung Function Abnormalities in Smokers with Ischemic Heart Disease

Franssen, F. M. E. (author)
Soriano, J. B. (author)
Roche, N. (author)
show more...
Bloomfield, P. H. (author)
Brusselle, G. (author)
Fabbri, L. M. (author)
Garcia-Rio, F. (author)
Kearney, M. T. (author)
Kwon, N. (author)
Lundbäck, Bo, 1948 (author)
Gothenburg University,Göteborgs universitet,Krefting Research Centre
Rabe, K. F. (author)
Raillard, A. (author)
Muellerova, H. (author)
Cockcroft, J. R. (author)
show less...
 (creator_code:org_t)
2016
2016
English.
In: American Journal of Respiratory and Critical Care Medicine. - 1073-449X. ; 194:5, s. 568-576
  • Journal article (peer-reviewed)
Abstract Subject headings
Close  
  • Rationale: The aim of the ALICE (Airflow Limitation in Cardiac Diseases in Europe) study was to investigate the prevalence of airflow limitation in patients with ischemic heart disease and the effects on quality of life, healthcare use, and future health risk. Objectives: To examine prebronchodilator and post-bronchodilator spirometry in outpatients aged greater than or equal to 40 years with clinically documented ischemic heart disease who were current or former smokers. Methods: This multicenter, cross-sectional study was conducted in 15 cardiovascular outpatient clinics in nine European countries. Airflow limitation was defined as post-bronchodilator FEV1/FVC less than 0.70. Measurements and Main Results: Among the 3,103 patients with ischemic heart disease who were recruited, lung function was defined for 2,730 patients. Airflow limitation was observed in 30.5% of patients with ischemic heart disease: 11.3% had mild airflow limitation, 15.8% moderate airflow limitation, 3.3% severe airflow limitation, and 0.1% very severe airflow limitation. Most patients with airflow limitation (70.6%) had no previous spirometry testing or diagnosed pulmonary disease. Airflow limitation was associated with greater respiratory symptomatology, impaired health status, and more frequent emergency room visits (P < 0.05). Conclusions: Airflow limitation compatible with chronic obstructive pulmonary disease affects almost one-third of patients with ischemic heart disease. Although airflow limitation is associated with additional morbidity and societal burden, it is largely undiagnosed and untreated.

Subject headings

MEDICIN OCH HÄLSOVETENSKAP  -- Klinisk medicin (hsv//swe)
MEDICAL AND HEALTH SCIENCES  -- Clinical Medicine (hsv//eng)

Keyword

airflow limitation
chronic obstructive pulmonary disease
smoking
prevalence
ischemic heart disease
obstructive pulmonary-disease
air-flow limitation
coronary-artery-disease
copd assessment test
cardiovascular risk
systematic analysis
physical-activity
vital capacity
global burden
population
General & Internal Medicine
Respiratory System

Publication and Content Type

ref (subject category)
art (subject category)

Find in a library

To the university's database

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view